REWARDS Premier Taxus-Liberte vs Xience V

NCT02256527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 917

Last updated 2016-07-14

No results posted yet for this study

Summary

Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.

Conditions

Interventions

OTHER

Observational

compare data

Sponsors & Collaborators

  • Medstar Health Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02256527 on ClinicalTrials.gov